Fundai

Caspian Tamin Pharmaceutical Company (KASPIAN) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
KASPIAN
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 6-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations1,922,9132,550,0491,319,7501,838,6332,196,561-96,303
Cash payments for income tax-1,485,847-218,106-356,373-300,173-131,509-83,697
Net cash inflow (outflow) from operating activities437,0662,331,943963,3771,538,4602,065,052-180,000
Cash payments for purchase of property, plant and equipment-97,084-212,182-220,339-174,059-275,046-180,104
Cash receipts from sale of intangible assets130,22300000
Cash payments for purchase of intangible assets-1,977-1,441-423-9,514-1,059-4,052
Cash receipts from dividends21600000
Cash receipts from interest on other investments5,6927,1236,7505,1735,1805,940
Net cash inflow (outflow) from investing activities37,070-206,500-218,694-210,888-304,167-198,808
Net cash inflow (outflow) before financing activities474,1362,125,443744,6831,327,5721,760,885-378,808
Cash receipts from facilities21,830,82010,587,6357,272,8976,501,6122,968,5104,840,783
Cash payments for principal of loans-15,544,492-9,759,718-4,748,197-5,689,554-4,155,844-3,680,349
Cash payments for interest on loans-2,946,562-1,943,818-1,264,513-633,821-446,287-446,972
Cash payments for dividends-2,923,680-921,897-1,514,155-1,529,383-14,733-280,898
Net cash inflow (outflow) from financing activities416,086-2,037,798-258,046-1,336,233-1,621,869431,250
Net increase (decrease) in cash890,22287,645486,637-8,661139,01652,442
Cash balance at beginning of year4,603,5631,887,401896,538577,263143,536175,672
Effect of changes in exchange rates101,3668,99623,7041,750-195-138
Cash balance at end of year5,595,1511,984,0421,406,879570,352282,357227,976

Reporting periods

47 periods are on file for this report, from the period ending 1392/12/29 to the period ending 1405/06/31.